These supply a benefit over peptide vaccines as they incorporate both of those HLA course I and II epitopes and hence usually are not subject to HLA limits. Moreover, they could drastically activate T cells, resulting in an Improved immune response and greater T cell activation. While this approach hasn't https://www.directivepublications.org/journal-of-clinical-breast-cancer/